Product nameAnti-PSMD12 antibody
See all PSMD12 primary antibodies
DescriptionRabbit polyclonal to PSMD12
Tested applicationsSuitable for: WB, IHC-Pmore details
Species reactivityReacts with: Human
Predicted to work with: Mouse, Rat, Chicken, Xenopus laevis
Recombinant fragment within Human PSMD12 (internal sequence). The exact sequence is proprietary.
Database link: O00232
- WB: NT2/D1, IMR32, U87-MG, whole cell lysates. IHC-P: Human breast cancer tissue.
This product was previously labelled as 26S proteasome non-ATPase regulatory subunit 12
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C. Avoid freeze / thaw cycle.
Storage bufferpH: 7.00
Preservative: 0.01% Thimerosal (merthiolate)
Constituents: 1.21% Tris, 0.75% Glycine, 20% Glycerol
Concentration information loading...
PurityImmunogen affinity purified
Our Abpromise guarantee covers the use of ab228902 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/5000 - 1/20000. Predicted molecular weight: 53 kDa.|
|IHC-P||1/100 - 1/1000.|
FunctionActs as a regulatory subunit of the 26S proteasome which is involved in the ATP-dependent degradation of ubiquitinated proteins.
Sequence similaritiesBelongs to the proteasome subunit p55 family.
Contains 1 PCI domain.
- Information by UniProt
- 26S proteasome non-ATPase regulatory subunit 12 antibody
- 26S proteasome regulatory subunit p55 antibody
- 26S proteasome regulatory subunit RPN5 antibody
Paraffin-embedded human breast cancer tissue stained for PSMD12 protein using ab228902 at 1/500 dilution in immunohistochemical analysis.
All lanes : Anti-PSMD12 antibody (ab228902) at 1/10000 dilution
Lane 1 : NT2/D1 (human embryonal testis carcinoma cell line) whole cell lysate
Lane 2 : IMR32 (human brain neuroblast cell line) whole cell lysate
Lane 3 : U87-MG (human glioblastoma-astrocytoma epithelial cell line) whole cell lysate
Lysates/proteins at 30 µg per lane.
Developed using the ECL technique.
Predicted band size: 53 kDa
10% SDS-PAGE gel.
ab228902 has not yet been referenced specifically in any publications.